Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Case report

Endovascular treatment of thoracic aortic pseudoaneurysm due to brucellosis: a rare case report

Authors: Shuai Wang, Qi Wang, Han Liu, Siqiao Sun, Xiwei Sun, Yang Zhang, Zhongying Wang, Zhihua Cheng

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Arterial damage is a known complication of brucellosis, but the occurrence of a thoracic aortic pseudoaneurysm secondary to brucellosis has not been previously reported.

Case presentation

A 65-year-old Chinese man presented with a pseudoaneurysm in the descending segment of the thoracic aorta that caused symptoms of chest pain and intermittent fever. He was diagnosed with a thoracic aortic pseudoaneurysm secondary to brucellosis based on a positive brucella serology test (standard-tube agglutination test) and imaging examination (computed tomography angiography). Anti-brucellosis treatment and covered stent graft implantation were attempted to eliminate the brucellosis and pseudoaneurysm, respectively, and were ultimately successful, with no symptoms after 6 months of follow-up.

Conclusion

Endovascular repair may be effective and safe for treating a thoracic aortic pseudoaneurysm resulting from brucellosis.
Literature
1.
Colomba C, Siracusa L, Rubino R, Trizzino M, Scarlata F, Imburgia C, et al. A case of Brucella endocarditis in association with subclavian artery thrombosis. Case rep Infect dis. 2012;581489
2.
Cui BY. Epidemic surveillance and control of brucellosis in China. Disease Surveillance. 2007;22(10):649–51.
3.
Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J med. 2005;352(22):2325–36.CrossRefPubMed
4.
Reguera JM, Alarcon A, Miralles F, Pachon J, Juarez C, Colmenero JD. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect dis. 2003;22(11):647–50.CrossRefPubMed
5.
Harman M, Irmak H, Arslan H, Arslan U, Kayan M. Popliteal artery pseudoaneurysm: a rare complication of brucellosis. J Clin Ultrasound. 2004;32(1):33–6.CrossRefPubMed
6.
Ustuner E, Erden A, Fitoz S, Erden I, Sancak T. Deep femoral artery pseudoaneurysm due to brucellosis. J Ultrasound med. 2001;20(12):1353–6.CrossRefPubMed
7.
Bergeron P, Gonzales-Fajardo J, Mangialardi N, Courbier R. False aneurysm of the abdominal aorta due to Brucella suis. Ann Vasc Surg. 1992;6(5):460–3.CrossRefPubMed
8.
Ferrero MC, Bregante J, Delpino MV, Barrionuevo P, Fossati CA, Giambartolomei GH, et al. Proinflammatory response of human endothelial cells to Brucella infection. Microbes Infect. 2011;13(10):852–61.CrossRefPubMed
9.
Gelfand MS, Kaiser AB, Dale WA. Localized brucellosis: popliteal artery aneurysm, mediastinitis, dementia, and pneumonia. Rev Infect dis. 1989;11(5):783–8.CrossRefPubMed
10.
Zaidan R, Al Tahan AR. Cerebral venous thrombosis: a new manifestation of neurobrucellosis. Clin Infect dis. 1999;28(2):399–400.CrossRefPubMed
11.
Yrivarren JL, Lopez LR. Cryoglobulinemia and cutaneous vasculitis in human brucellosis. J Clin Immunol. 1987;7(6):471–4.CrossRefPubMed
12.
Odeh M, Pick N, Oliven A. Deep venous thrombosis associated with acute brucellosis--a case report. Angiology. 2000;51(3):253–6.CrossRefPubMed
13.
Andrew WK. An unusual cause of deep venous thrombosis of the lower limb. S Afr med J. 2000;90(1):42.PubMed
14.
Caylan R, Keske S, Durmaz T, Keles T, Tasyaran MA. A case of Brucella endocarditis in association with superficial femoral artery thrombus. Trop Dr. 2009;39(4):251–2.CrossRef
15.
Prasad S, Lingadakai R, Chethan K, Abdul Z. Superior mesenteric artery syndrome secondary to brucellosis - a case report. Indian J Surg. 2010;72(3):265–7.CrossRefPubMedPubMedCentral
16.
17.
Trevisani MF, Ricci MA, Michaels RM, Meyer KK. Multiple mesenteric aneurysms complicating subacute bacterial endocarditis. Arch Surg. 1987;122(7):823–4.CrossRefPubMed
18.
Dean RH, Waterhouse G, Meacham PW, Weaver FA, O'Neil JA Jr. Mycotic embolism and embolomycotic aneurysms. Neglected lessons of the past. Ann Surg. 1986;204(3):300–7.CrossRefPubMedPubMedCentral
19.
Togan T, Ciftci O, Turan H, Narci H, Gullu H, Arslan H. Could there be an association between chronic brucellosis and endothelial damage? J Infect dev Ctries. 2015;9(1):48–54.CrossRefPubMed
20.
Gursoy MO, Tursun I, Alpua M, Haykir Solay A, Tokat Cobanli M, Demirtas H, et al. Brucellosis impairs endothelial functions in chronic symptomatic patients without overt cardiac involvement. Turk Kardiyol Dern Ars 2015; 43(3): 242–249.CrossRefPubMed
21.
Cheng Z, Luo SX, Sun X, Sun S, Wang Z, Jiang Y, et al. Surgical treatment of syphilitic superficial femoral artery aneurysm: a rare case report. BMC Infect dis. 2015;15:540.CrossRefPubMedPubMedCentral
22.
Inaba Y, Ito T, Hayashi S, Iida Y, Misumi T, Shimizu H. Surgical strategy for thoracic aortic Pseudoaneurysm with sternal adherence. Ann Vasc dis. 2016;9(3):235–9.CrossRefPubMedPubMedCentral
23.
Goodney PP, Travis L, Lucas FL, Fillinger MF, Goodman DC, Cronenwett JL, et al. Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population. Circulation. 2011;124(24):2661–9.CrossRefPubMedPubMedCentral
24.
Solis Garcia del Pozo J, Solera J. Systematic Review and Meta-Analysis of Randomized Clinical Trials in the Treatment of Human Brucellosis. PLoS One. 2012; 7(2): e32090.
Metadata
Title
Endovascular treatment of thoracic aortic pseudoaneurysm due to brucellosis: a rare case report
Authors
Shuai Wang
Qi Wang
Han Liu
Siqiao Sun
Xiwei Sun
Yang Zhang
Zhongying Wang
Zhihua Cheng
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2485-7

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue

Research article

Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey

Research article

Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis

Research article

Impact of HPV vaccination with Gardasil® in Switzerland

Research article

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia

Research article

Implementing and sustaining a mobile medical clinic for prenatal care and sexually transmitted infection prevention in rural Mysore, India

Research article

Predictive accuracy of particle filtering in dynamic models supporting outbreak projections
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits